ZHICHENG BIO
L-theanine: when someone put six commercial products on a chiral column, five contained D-theanine
The only guide in this set where the failure rate has actually been counted — and it was five out of six.
The short answer
In the published chiral analysis of commercial "L-theanine" products, five of six contained significant amounts of D-theanine. The work, by Desai and Armstrong, used a teicoplanin chiral stationary phase with HPLC coupled to atmospheric-pressure-ionisation mass spectrometry, confirmed by photodiode array detection; only one of the six products appeared to contain the L-enantiomer alone. None of this is visible on a conventional certificate of analysis, because a standard reversed-phase assay reports total theanine and enantiomers co-elute on achiral phases. Whether a batch is L or DL is determined by the manufacturing route — and the route is not printed on the certificate either.
- The molecule
- L-theanine, C7H14N2O3, Mr 174.20, CAS 3081-61-6. D-theanine: CAS 5822-62-8
- What was found
- Six commercially available L-theanine samples analysed; five contained significant amounts of D-theanine; one appeared to contain only the L-enantiomer (Desai MJ, Armstrong DW, Rapid Commun Mass Spectrom 2004, PMID 14755608)
- The method used
- Chirobiotic T (teicoplanin) chiral stationary phase; HPLC with atmospheric pressure ionisation mass spectrometry; confirmed with photodiode array detection. Native and derivatised theanine both separated
- The pharmacokinetic follow-up
- Gut absorption of d-theanine was reported to be far less than that of l-theanine in rats (Chirality 2005, doi 10.1002/chir.20144)
- Why the routes differ
- Enzymatic and fermentation routes transfer the glutamyl group to ethylamine and give the L-form; chemical synthesis can produce the racemate depending on the route
- Why your COA is silent
- Enantiomers have identical retention on achiral columns. "Theanine ≥ 98% by HPLC" is a statement about total theanine unless a chiral stationary phase is named in the method
The measurement
In 2004 Desai and Armstrong published a chiral method for theanine in Rapid Communications in Mass Spectrometry: a Chirobiotic T column — a teicoplanin-based chiral stationary phase — run on HPLC with atmospheric-pressure-ionisation mass spectrometric detection, capable of resolving both native and derivatised theanine enantiomers, with photodiode array detection as confirmation.
They then applied it to six commercially available L-theanine products. Five of the six contained significant amounts of D-theanine. One — the branded enzymatic product — appeared to contain only the L-enantiomer.
It is worth being careful about the scope of that finding. It is one study, from 2004, on six samples of finished commercial material, and the market has moved since; nobody should read it as a current market-share statistic. What it establishes, and establishes firmly, is that D-theanine in material sold as L-theanine is a real and documented occurrence rather than a theoretical worry, and that the only way anyone found out was by putting it on a chiral column.
A companion study in Chirality the following year reported the pharmacokinetics of the two enantiomers in rats, finding that gut absorption of d-theanine was far less than that of l-theanine. That is a pharmacokinetic observation, not a claim about outcomes, and this page does not extend it into one.
Why chemistry produces the problem and why the certificate hides it
Theanine is γ-glutamylethylamide. The enzymatic route builds it the way tea plants do: a glutaminase or γ-glutamyltranspeptidase transfers the glutamyl group from glutamine onto ethylamine, and because the enzyme's active site is chiral, the product carries the L configuration. Fermentation routes work on the same principle.
A purely chemical synthesis has no such constraint. Depending on the route and the starting materials, it can deliver the racemate — equal parts L and D — at which point a resolution step is the only thing standing between the reactor and a 50:50 product. Whether that step exists is a fact about a specific process, and it is exactly the sort of fact that a supplier switching contract manufacturers may not think to mention.
The certificate cannot catch it, and it is worth being clear about why. Enantiomers have the same molecular mass, the same UV absorbance, the same behaviour in an achiral solvent and the same retention time on an achiral C18 column. "Theanine ≥ 98.0% by HPLC" is therefore a correct and complete statement about total theanine, produced by a competent laboratory, that carries zero information about enantiomeric composition. The laboratory is not hiding anything; it answered the question the specification asked.
How to buy this material
Specify the enantiomer in the identity line and then specify a test that can verify it. "L-theanine, CAS 3081-61-6" plus "Assay ≥ 98.0% (HPLC)" plus "Enantiomeric purity: D-theanine ≤ 1.0%, by chiral HPLC" — with the chiral stationary phase named and the chromatogram required — is a specification that a racemate cannot satisfy.
Ask for the manufacturing route in writing: enzymatic, fermentation, extraction from tea, or chemical synthesis, and if chemical, whether a resolution step is included. Keep it in the supplier file and treat a change of route as a change requiring requalification, because it is the event most likely to move the enantiomeric purity without moving any number on the certificate.
Add specific optical rotation as a corroborating check, with concentration, solvent and temperature stated — the same discipline as for any rotation figure. It is cheap, it is fast, and while it is not sensitive enough to be a limit test on its own, a rotation that is markedly low is a signal worth chasing before the container ships.
And test on receipt at least once per new supplier. A chiral run on the first lot costs very little against the cost of finding out later, and it converts a supplier's claim into your own data.
What this does and does not mean commercially
The commercial reality is that L-theanine and DL-theanine have different costs to make, because the enzymatic route and a resolution step both cost money that a straight racemic synthesis does not. A price that is conspicuously below the market is information, and the specific thing it is most often information about, in this molecule, is stereochemistry.
That does not make a racemic material fraudulent in itself. There are applications where a buyer may decide the difference does not matter to them, and that is a legitimate commercial decision. What is not legitimate is selling a racemate as L-theanine, and the reason it happens is that the standard test cannot tell the difference and most buyers never ask for one that can.
This page makes no claim about the physiological effects of either enantiomer. It is about what you contracted for and how to verify you received it. The identical structure applies to L-carnitine, where the pharmacopoeial assay is a titration, and to L-ergothioneine, where the EU has written the enantiomer into the authorised name.
Frequently asked
Do commercial L-theanine products actually contain D-theanine?
In the published chiral analysis, yes, frequently. Desai and Armstrong (Rapid Commun Mass Spectrom 2004, PMID 14755608) analysed six commercially available L-theanine samples using a teicoplanin chiral stationary phase with HPLC-mass spectrometry and found significant amounts of D-theanine in five of them; only one appeared to contain the L-enantiomer alone. That is a 2004 study on six samples and should not be read as a current market statistic, but it establishes that the problem is documented rather than theoretical.
Can a normal HPLC assay tell L-theanine from DL-theanine?
No. Enantiomers have identical retention on achiral stationary phases, so a conventional reversed-phase method reports total theanine. Distinguishing them requires a chiral stationary phase, or derivatisation with a chiral reagent followed by achiral separation. If the method section of your specification does not name one, the assay figure says nothing about which enantiomer you have.
Which manufacturing routes give pure L-theanine?
Enzymatic synthesis and fermentation, which transfer the glutamyl group onto ethylamine through a chiral enzyme active site, give the L configuration; extraction from tea likewise gives the natural L-form. Chemical synthesis may give the racemate depending on the route, in which case only a resolution step separates the reactor output from a 50:50 mixture. Ask for the route in writing and treat a route change as requiring requalification.
What should an L-theanine specification say?
Identity as L-theanine with CAS 3081-61-6; assay by HPLC with a minimum; and a separate enantiomeric purity line setting a numerical maximum for D-theanine by chiral HPLC, with the chiral stationary phase named and the chromatogram supplied. Specific optical rotation with stated concentration, solvent and temperature is a useful corroborating check but is not sensitive enough to serve as the limit test.
This page describes raw-material sourcing and specification. It is not a health claim and not medical advice. Last updated 2026-08-07.